NDC 33261-049 Gabapentin
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Product Characteristics
YELLOW (C48330 - BUFF-BUFF)
19 MM
IP102
Product Packages
NDC Code 33261-049-00
Package Description: 100 CAPSULE in 1 BOTTLE
NDC Code 33261-049-02
Package Description: 120 CAPSULE in 1 BOTTLE
NDC Code 33261-049-10
Package Description: 10 CAPSULE in 1 BOTTLE
NDC Code 33261-049-20
Package Description: 20 CAPSULE in 1 BOTTLE
NDC Code 33261-049-21
Package Description: 21 CAPSULE in 1 BOTTLE
NDC Code 33261-049-30
Package Description: 30 CAPSULE in 1 BOTTLE
NDC Code 33261-049-42
Package Description: 42 CAPSULE in 1 BOTTLE
NDC Code 33261-049-45
Package Description: 45 CAPSULE in 1 BOTTLE
NDC Code 33261-049-60
Package Description: 60 CAPSULE in 1 BOTTLE
NDC Code 33261-049-81
Package Description: 81 CAPSULE in 1 BOTTLE
NDC Code 33261-049-90
Package Description: 90 CAPSULE in 1 BOTTLE
NDC Code 33261-049-97
Package Description: 126 CAPSULE in 1 BOTTLE
NDC Code 33261-049-99
Package Description: 180 CAPSULE in 1 BOTTLE
Product Details
What is NDC 33261-049?
What are the uses for Gabapentin?
Which are Gabapentin UNII Codes?
The UNII codes for the active ingredients in this product are:
- GABAPENTIN (UNII: 6CW7F3G59X)
- GABAPENTIN (UNII: 6CW7F3G59X) (Active Moiety)
What is the NDC to RxNorm Crosswalk for Gabapentin?
- RxCUI: 310430 - gabapentin 100 MG Oral Capsule
- RxCUI: 310431 - gabapentin 300 MG Oral Capsule
- RxCUI: 310432 - gabapentin 400 MG Oral Capsule
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".